PMID- 24587184 OWN - NLM STAT- MEDLINE DCOM- 20141028 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 9 IP - 2 DP - 2014 TI - Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma. PG - e90007 LID - 10.1371/journal.pone.0090007 [doi] LID - e90007 AB - PURPOSE: The objective of this study was to evaluate the dosimetric feasibility of using hippocampus (HPC) sparing intensity-modulated radiotherapy (IMRT) in patients with locally advanced nasopharyngeal carcinoma (NPC). MATERIALS/METHODS: Eight cases of either T3 or T4 NPC were selected for this study. Standard IMRT treatment plans were constructed using the volume and dose constraints for the targets and organs at risk (OAR) per Radiation Therapy Oncology Group (RTOG) 0615 protocol. Experimental plans were constructed using the same criteria, with the addition of the HPC as an OAR. The two dose-volume histograms for each case were compared for the targets and OARs. RESULTS: All plans achieved the protocol dose criteria. The homogeneity index, conformity index, and coverage index for the planning target volumes (PTVs) were not significantly compromised by the avoidance of the HPC. The doses to all OARs, excluding the HPC, were similar. Both the dose (Dmax, D2%, D40%, D mean, D median, D98% and D min) and volume (V5, V10, V15, V20, V30, V40 and V50) parameters for the HPC were significantly lower in the HPC sparing plans (p<0.05), except for D min (P = 0.06) and V5 (P = 0.12). CONCLUSIONS: IMRT for patients with locally advanced NPC exposes the HPC to a significant radiation dose. HPC sparing IMRT planning significantly decreases this dose, with minimal impact on the therapeutic targets and other OARs. FAU - Han, Guang AU - Han G AD - Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, PR China. FAU - Liu, Dong AU - Liu D AD - Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, PR China. FAU - Gan, Hua AU - Gan H AD - Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America. FAU - Denniston, Kyle A AU - Denniston KA AD - Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America. FAU - Li, Sicong AU - Li S AD - Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America. FAU - Tan, Wenyong AU - Tan W AD - Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, PR China. FAU - Hu, Desheng AU - Hu D AD - Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, PR China. FAU - Zhen, Weining AU - Zhen W AD - Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America. FAU - Wang, Zhaohua AU - Wang Z AD - Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, PR China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140228 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Carcinoma MH - Hippocampus MH - Humans MH - Nasopharyngeal Carcinoma MH - Nasopharyngeal Neoplasms/pathology/*radiotherapy MH - Neoplasm Staging MH - Organ Sparing Treatments/*methods MH - Organs at Risk MH - Radiometry MH - Radiotherapy Dosage MH - *Radiotherapy Planning, Computer-Assisted MH - Radiotherapy, Intensity-Modulated/*methods PMC - PMC3938567 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2014/03/04 06:00 MHDA- 2014/10/29 06:00 PMCR- 2014/02/28 CRDT- 2014/03/04 06:00 PHST- 2013/12/11 00:00 [received] PHST- 2014/01/24 00:00 [accepted] PHST- 2014/03/04 06:00 [entrez] PHST- 2014/03/04 06:00 [pubmed] PHST- 2014/10/29 06:00 [medline] PHST- 2014/02/28 00:00 [pmc-release] AID - PONE-D-13-52010 [pii] AID - 10.1371/journal.pone.0090007 [doi] PST - epublish SO - PLoS One. 2014 Feb 28;9(2):e90007. doi: 10.1371/journal.pone.0090007. eCollection 2014.